Within the context of a cooperative venture with the Centre for Biomedical Nanotechnology, a non-profit organization founded by Dr. Andreas Jordan, MagForce is currently participating as a partner in various support projects. But even before the company was founded, the research of Dr. Jordan on Nano-Cancer^® therapy was supported by renowned institutions.

12/1989 - 1993

Participation in founding Initiative 1470 for setting up a special research field of the Deutsche Forschungsgemeinschaft (DFG = German Research Association) about the subject of "hyperthermia"

02/1990 - 1992

Approval of the first third-party application to Deutsche Krebshilfe (= German Cancer Aid), Dr. Mildred Scheel Foundation for Cancer Research, Bonn

06/1992

Successful renewal application to Deutsche Krebshilfe on the subject of "Magnetic Field Ferrite Hyperthermia" for another two years

07/1994

Approval of the special research field (SFB) 273 in Berlin: "Hyperthermia: Methodology and Clinical Application" (speaker: Prof. Dr. Dr. R. Felix)

1994

Project management of the SFB partial project C2: "H field induced hyperthermia with magnetic fluids"

1998 - 2001

Continuation of the special research field (SFB) 273. Project management of the SFB partial projects A8 and C10, as well as in the partial project C7 and in the graduate collegium 331

2000 - 2006

EFRE infrastructure measure "NanoMed – Nanotechnology in Medicine"

03/2002 - 02/2004

Project of the Federal Ministry for Education and Research (BMBF = Bundesministerium für Bildung und Forschung): "Multiple-coating nanocarriers for the cell-specific thermochemotherapy of cancer"

11/2004 - 10/2006

Project of the Federal Ministry for Education and Research (BMBF = Bundesministerium für Bildung und Forschung): "Thermally activated nanocarriers (TAN) to fight cancer"

2007 - 2011

Project of the European Commission: "Targeted Delivery of Nanomedicine" (MediTrans)

2009 - 2012

Magnetic nanocontainers for combined hyperthermia and controlled drug release (MAGNIFYCO)